Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated

T Tsakiridis1, E Tsiani, P Lekas

  • 1Clinical Sciences Division, Department of Medicine, University of Toronto, 1 King's College Circle, Toronto, Ontario, Canada M5S 1A8.

Insights

Insulin, IGF-I, and PDGF activate extracellular signal-regulated kinase (ERK) through distinct pathways in L6 myotubes. Insulin uses a Ras-dependent route, PDGF a PKC-dependent route, and IGF-I an independent route.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Endocrinology

Background:

  • Insulin, IGF-I, and PDGF are key growth factors regulating cellular processes.
  • Extracellular signal-regulated kinase (ERK) is a crucial mediator of cell growth and differentiation.
  • Understanding the specific signaling cascades activated by these growth factors is essential for elucidating cellular responses.

Purpose of the Study:

  • To investigate and delineate the distinct signaling pathways utilized by insulin, IGF-I, and PDGF for ERK activation in L6 myotubes.
  • To identify the roles of Ras, protein kinase C (PKC), and the cytoskeleton in mediating these signaling events.

Main Methods:

  • Utilized specific inhibitors: farnesyl transferase inhibitor (FTPIII) for Ras, cytochalasin D for actin disassembly, bisindolylmaleimide for PKC, wortmannin for PI3K, and PD98059 for MEK.
  • Assessed ERK activation in response to insulin, IGF-I, and PDGF in L6 myotubes under various inhibitory conditions.
  • Investigated the PI3K/Akt/GSK3 pathway activation by these growth factors.

Main Results:

  • Insulin-induced ERK activation was dependent on Ras and the cytoskeleton but independent of PKC.
  • PDGF-induced ERK activation was dependent on PKC but independent of Ras and the cytoskeleton.
  • IGF-I-induced ERK activation was independent of Ras, PKC, and the cytoskeleton.
  • All three growth factors activated the PI3K/Akt/GSK3 pathway via a Ras- and actin-independent mechanism.

Conclusions:

  • ERK activation by insulin, IGF-I, and PDGF is mediated by distinct signaling modules.
  • Insulin utilizes a Ras- and cytoskeleton-dependent pathway.
  • PDGF employs a PKC-dependent pathway.
  • IGF-I activates ERK through a pathway independent of Ras, cytoskeleton, and PKC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...